<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100796">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792375</url>
  </required_header>
  <id_info>
    <org_study_id>SWP_PG_Null</org_study_id>
    <nct_id>NCT01792375</nct_id>
  </id_info>
  <brief_title>Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare concurrent membrane sweeping with dinoprostone versus dinoprostone in labor
      induction for nulliparas at term with an unfavorable cervix
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal delivery within 24 hours</measure>
    <time_frame>Twenty-four hours of initiating intervention (i.e. membrane sweeping or PG) on the first day of induction</time_frame>
    <description>Vaginal delivery within 24 hours is defined as vaginal delivery after 24 hours of initiating intervention (i.e. concurrent membrane sweeping with dinoprostone or only dinoprostone) on the first day of induction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cervical change in the bishop scores and cervical lengths</measure>
    <time_frame>Initiation of oxytocin after removing dinoprostone vaginal insert</time_frame>
    <description>Cervical change based on the bishop score and cervical length induced by two cervical ripening methods(concurrent membrane sweeping with dinoprostone vs. dinoprostone)
Incidence of cesarean delivery
Successful labor induction (defined as an ability to achieve the active phase of labor corresponding to a cervical dilatation of &gt;=4cm).
The interval from start of oxytocin to delivery
Incidence of rupture of membranes
Incidences of vaginal bleeding and fever</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Nulliparous Women Who Scheduled for Labor Induction</condition>
  <arm_group>
    <arm_group_label>Concurrent membrane sweeping with Dinoprostone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dinoprostone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Concurrent membrane sweeping with Dinoprostone</intervention_name>
    <description>Women assigned to &quot;Sweep&quot; had their cervix swept by inserting the examining finger as high as possible past the internal cervical os, immediately followed by the placement of a 10mg Dinoprostone vaginal insert in the posterior fornix.</description>
    <arm_group_label>Concurrent membrane sweeping with Dinoprostone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10mg Dinoprostone vaginal insert</intervention_name>
    <description>For women assigned to &quot;No sweep&quot;: The only 10mg Dinoprostone vaginal insert were placed in the posterior fornix for cervical ripening</description>
    <arm_group_label>Dinoprostone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton pregnancy

          -  Nulliparous women

          -  gestational age &gt;=37.0 weeks

          -  Bishop score &lt;=6

          -  intact amniotic membrane

          -  absence of labor

          -  live fetus with vertex presentation

          -  no previous uterine surgical procedure

        Exclusion Criteria:

          -  Multiple pregnancy

          -  Placenta previa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyo Hoon Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyo Hoon Park, MD, PhD</last_name>
    <phone>82-31-787-7252</phone>
    <email>pkh0419@snubh.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyo Hoon Park, MD, PhD</last_name>
      <phone>82-31-787-7252</phone>
      <email>pkh0419@snubh.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 12, 2016</lastchanged_date>
  <firstreceived_date>February 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical ripening</keyword>
  <keyword>Dinoprostone</keyword>
  <keyword>Labor induction</keyword>
  <keyword>Membrane sweeping</keyword>
  <keyword>Nulliparous women</keyword>
  <keyword>Trial</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
